Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Image: Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group, expanding the company’s pathology portfolio across clinical and research settings

Agilent Strengthens Pathology Capabilities Through Biocare Acquisition

Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group, expanding its clinical and research pathology portfolio. More...
29 Jun 2026
Image: The planned Bio-Techne acquisition would strengthen Merck KGaA, Darmstadt, Germany, in multi-omics, spatial biology, cell and gene therapy, precision diagnostics, and research tools.

Merck KGaA to Acquire Bio-Techne, Expanding Life Science Portfolio

Merck KGaA agrees to acquire Bio-Techne, strengthening its leadership position in fast-growing life sciences markets. More...
29 Jun 2026
DB function failed with error number 0

Gene Variants Linked to Pollution-Exacerbated Asthma

More...
28 Jun 2026
Image: New EMBL-led research identifies a robust gut microbiome signature linked to colorectal cancer, consistent across populations, sequencing methods & age groups, and tied to lower dietary fiber intake. (Photo courtesy of Daniela Velasco/EMBL)

Machine Learning Reveals Consistent Gut Microbiome Patterns in Colorectal Cancer

An AI approach integrates diverse sequencing data to identify a reproducible colorectal cancer microbiome signature. More...
26 Jun 2026
Image: The HepQuant SHUNT Liver Diagnostic Test assesses chronic liver disease physiology by measuring  clearances of intravenously administered cholate and orally administered cholate that reflect liver blood flow and hepatocyte function (Image credit: iStock)

FDA-Approved Test Identifies Low Risk of Large Esophageal Varices in Cirrhosis

A new test quantifies risk of large esophageal varices in compensated cirrhosis, helping avoid unnecessary endoscopy. More...
26 Jun 2026
Image: Researchers reveal that in Sjögren disease, an autoimmune disease, not only immune cells but also the fibroblasts that make up the tissue are actively involved in the progression of the disease. CD153+ CD4+ T cells interact with CD30+ fibroblasts in primary Sjögren disease, amplifying inflammation and tissue damage. This pathological cellular interaction represents a potential therapeutic target for autoimmune Sjögren disease. (Photo courtesy of Professor Koji Yasutomo, Tokushima University, Japan)

New Cellular Biomarkers Correlate with Disease Severity in Sjögren Disease

New findings reveal an immune-fibroblast pathway in primary Sjögren disease that may serve as a novel biomarker for diagnosis or monitoring. More...
26 Jun 2026
Image: a new initiative aims to bring greater precision to this class of therapeutics (Photo courtesy of One Biosciences)

Project Aims to Develop First Single-Cell Assay for ADC Therapies

One Biosciences receives Paris Saclay Cancer Cluster BOOST funding to advance a single-cell assay approach for antibody-drug conjugate therapies. More...
26 Jun 2026
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
HPV Test
Allplex HPV28 Detection
Multi-Chamber Washer-Disinfector
WD 390
Copyright © 2000-2026 Globetech Media. All rights reserved.